We are live on ! Find out more
SILK

Silk Road Medical, Inc. Common Stock

Delisted

SILK was delisted on the 16th of September, 2024.

166 hedge funds and large institutions have $597M invested in Silk Road Medical, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 74 increasing their positions, 52 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more call options, than puts

Call options by funds: $8.44M | Put options by funds: $4.96M

42% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 52

4% less funds holding

Funds holding: 173166 (-7)

19% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 36

58% less capital invested

Capital invested by funds: $1.42B → $597M (-$824M)

Holders
166
Holders Change
-7
Holders Change %
-4.05%
% of All Funds
2.63%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
74
Reduced
52
Closed
36
Calls
$8.44M
Puts
$4.96M
Net Calls
+$3.48M
Net Calls Change
+$3.72M
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$5.82M +$2.9M +139,301 +56%
CSS
27
Cubist Systematic Strategies
Connecticut
$5.69M +$4.68M +224,709 +145%
PAMP
28
Polar Asset Management Partners
Ontario, Canada
$5.5M +$7.64M +366,983 New
PCM
29
Peregrine Capital Management
Minnesota
$5.12M -$442K -21,235 -6%
NHAS
30
Novo Holdings A/S
Denmark
$5M
BNP Paribas Asset Management
31
BNP Paribas Asset Management
France
$4.85M -$6.18M -297,073 -48%
Charles Schwab
32
Charles Schwab
California
$4.47M +$201K +9,667 +3%
SAM
33
Silvercrest Asset Management
New York
$3.91M +$3.32M +159,758 +158%
PHP
34
Parkman Healthcare Partners
Connecticut
$3.74M -$1.21M -58,184 -19%
Goldman Sachs
35
Goldman Sachs
New York
$3.73M +$3.02M +144,939 +139%
Renaissance Technologies
36
Renaissance Technologies
New York
$3.11M -$2.74M -131,600 -39%
Adage Capital Partners
37
Adage Capital Partners
Massachusetts
$3M +$1.04M +50,000 +33%
PC
38
Pier Capital
Connecticut
$2.73M -$946K -45,450 -20%
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$2.72M +$2.2M +105,961 +140%
SSA
40
Schonfeld Strategic Advisors
New York
$2.49M -$335K -16,081 -9%
SEI Investments
41
SEI Investments
Pennsylvania
$2.44M +$296K +14,227 +10%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$2.34M +$492K +23,658 +18%
EGM
43
Engineers Gate Manager
New York
$2.33M +$663K +31,862 +26%
CM
44
Caption Management
Oklahoma
$2.26M +$3.13M +150,588 New
IHAM
45
Integral Health Asset Management
New York
$2.25M +$3.12M +150,000 New
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$2.11M +$2.49M +119,845 +572%
TC
47
TwinBeech Capital
New York
$1.9M +$2.64M +127,028 New
Millennium Management
48
Millennium Management
New York
$1.89M -$9.11M -437,926 -78%
SBH
49
Segall Bryant & Hamill
Illinois
$1.78M -$18.1K -869 -0.7%
N
50
Nuveen
North Carolina
$1.73M -$2.07M -99,601 -46%

SILK Hedge Fund Activity: Q3 2023 in Review

166 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2023, worth a combined $597M — down 58% from $1.42B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of SILK and 29 opened new positions — a net loss of 7 holders — while 52 trimmed existing stakes and 74 added.

The largest buyer was Granite Investment Partners, opening a new position worth an estimated $14.9M. The largest seller was AllianceBernstein, cutting an estimated $50.9M.

  • 166 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2023, down from 173 in Q2 2023.
  • Funds reported $597M of Silk Road Medical, Inc. Common Stock stock for Q3 2023, down 58% quarter-over-quarter.
  • 29 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2023 and 36 closed out, a net change of -7 holders.
  • The largest Silk Road Medical, Inc. Common Stock buyer in Q3 2023 was Granite Investment Partners, an estimated $14.9M added.
  • The largest Silk Road Medical, Inc. Common Stock seller in Q3 2023 was AllianceBernstein, an estimated $50.9M sold.

Based on aggregated 13F filings for Q3 2023.